• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名年轻女性在接受第一轮依库珠单抗治疗阵发性夜间血红蛋白尿后发生致命性中性粒细胞减少性小肠结肠炎。

Fatal Neutropenic Enterocolitis in a Young Female After the First Round of Eculizumab for Paroxysmal Nocturnal Hemoglobinuria.

作者信息

Miranda-Burgos Laura, Khan Aliya, Anand Gautam, Dabage-Forzoli Nemer

机构信息

Internal Medicine, Broward Health North, Deerfield Beach, USA.

Gastroenterology, Broward Health North, Deerfield Beach, USA.

出版信息

Cureus. 2024 Sep 10;16(9):e69088. doi: 10.7759/cureus.69088. eCollection 2024 Sep.

DOI:10.7759/cureus.69088
PMID:39391389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11466055/
Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disorder characterized by glycosylphosphatidylinositol (GPI)-linked membrane protein deficiency, leading to hemolytic anemia and thrombosis. A subset of patients develop severe neutropenia, predisposing them to neutropenic enterocolitis (NEC). We present a case of fatal NEC following eculizumab therapy in a 31-year-old female with PNH. She presented with abdominal pain, fever, and neutropenia post-eculizumab. Despite aggressive management, including antibiotics and supportive care, she developed septic shock complicated by bacteremia, multiorgan failure, and two episodes of cardiac arrest, leading to severe lactic acidosis and ultimately progressing to brain death. The etiology of NEC in PNH patients remains multifactorial, involving immunocompromised and treatment-related factors. This case underscores the challenges in managing NEC and highlights the importance of early recognition and intervention in high-risk patients.

摘要

阵发性睡眠性血红蛋白尿症(PNH)是一种罕见的疾病,其特征是糖基磷脂酰肌醇(GPI)连接的膜蛋白缺乏,导致溶血性贫血和血栓形成。一部分患者会出现严重的中性粒细胞减少,使他们易患中性粒细胞减少性小肠结肠炎(NEC)。我们报告一例31岁患有PNH的女性在接受依库珠单抗治疗后发生致命性NEC的病例。她在接受依库珠单抗治疗后出现腹痛、发热和中性粒细胞减少。尽管采取了积极的治疗措施,包括使用抗生素和支持治疗,但她仍发展为感染性休克,并伴有菌血症、多器官功能衰竭和两次心脏骤停,导致严重的乳酸酸中毒,最终发展为脑死亡。PNH患者发生NEC的病因仍然是多因素的,涉及免疫功能低下和治疗相关因素。该病例强调了管理NEC的挑战,并突出了对高危患者进行早期识别和干预的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a327/11466055/e4ba22bcf2c7/cureus-0016-00000069088-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a327/11466055/e4ba22bcf2c7/cureus-0016-00000069088-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a327/11466055/e4ba22bcf2c7/cureus-0016-00000069088-i01.jpg

相似文献

1
Fatal Neutropenic Enterocolitis in a Young Female After the First Round of Eculizumab for Paroxysmal Nocturnal Hemoglobinuria.一名年轻女性在接受第一轮依库珠单抗治疗阵发性夜间血红蛋白尿后发生致命性中性粒细胞减少性小肠结肠炎。
Cureus. 2024 Sep 10;16(9):e69088. doi: 10.7759/cureus.69088. eCollection 2024 Sep.
2
A patient with paroxysmal nocturnal hemoglobinuria being treated with eculizumab who underwent laparoscopic cholecystectomy: report of a case.一名接受依库珠单抗治疗的阵发性夜间血红蛋白尿患者接受了腹腔镜胆囊切除术:病例报告。
Surg Case Rep. 2015;1(1):57. doi: 10.1186/s40792-015-0059-8. Epub 2015 Jul 11.
3
Case report: Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositol-deficient clones in paroxysmal nocturnal hemoglobinuria.病例报告:阵发性睡眠性血红蛋白尿症中,造血干细胞上的免疫压力可显著扩增糖基磷脂酰肌醇缺陷型克隆。
Front Immunol. 2024 Jan 15;14:1329403. doi: 10.3389/fimmu.2023.1329403. eCollection 2023.
4
Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria.依库珠单抗用于治疗阵发性夜间血红蛋白尿患者。
Cochrane Database Syst Rev. 2014 Oct 30(10):CD010340. doi: 10.1002/14651858.CD010340.pub2.
5
Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation.经典型阵发性睡眠性血红蛋白尿症及再生障碍性贫血-阵发性睡眠性血红蛋白尿症患者妊娠:一种高风险组合。
Front Med (Lausanne). 2020 Sep 24;7:543372. doi: 10.3389/fmed.2020.543372. eCollection 2020.
6
Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.依库珠单抗时代阵发性睡眠性血红蛋白尿症的造血干细胞移植。
Biol Blood Marrow Transplant. 2019 Jul;25(7):1331-1339. doi: 10.1016/j.bbmt.2019.01.033. Epub 2019 Feb 1.
7
Two Roads Diverge: Treatment Choice in Coexisting Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria.两条道路分岔:并存严重再生障碍性贫血和阵发性睡眠性血红蛋白尿症时的治疗选择
J Med Cases. 2020 Jun;11(6):182-184. doi: 10.14740/jmc3478. Epub 2020 May 28.
8
Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria.阵发性睡眠性血红蛋白尿症发病机制与治疗的最新进展
F1000Res. 2016 Feb 23;5. doi: 10.12688/f1000research.7288.1. eCollection 2016.
9
Deciphering Paroxysmal Nocturnal Hemoglobinuria: An Unusual Paradigm of Hemolytic Anemia.解读阵发性夜间血红蛋白尿:溶血性贫血的一种特殊模式
Cureus. 2024 Aug 19;16(8):e67194. doi: 10.7759/cureus.67194. eCollection 2024 Aug.
10
PNH is a debilitating, fatal but treatable disease: same disease, different clinical presentations.阵发性睡眠性血红蛋白尿症是一种使人虚弱、致命但可治疗的疾病:同一种疾病,不同的临床表现。
Am J Blood Res. 2015 Jun 15;5(1):30-3. eCollection 2015.

本文引用的文献

1
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs.接受依库珠单抗或其他补体抑制剂治疗的阵发性睡眠性血红蛋白尿症(PNH)患者的感染管理:未满足的临床需求。
Blood Rev. 2023 Mar;58:101013. doi: 10.1016/j.blre.2022.101013. Epub 2022 Sep 6.
2
A Rare Case of Paroxysmal Nocturnal Hemoglobinuria With Bilateral Renal Vein Thrombosis.一例罕见的伴有双侧肾静脉血栓形成的阵发性夜间血红蛋白尿病例。
Cureus. 2020 Jun 24;12(6):e8806. doi: 10.7759/cureus.8806.
3
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study.
瑞维鲁单抗(ALXN1210)与依库珠单抗在既往未接受补体抑制剂治疗的成人 PNH 患者中的比较:301 研究。
Blood. 2019 Feb 7;133(6):530-539. doi: 10.1182/blood-2018-09-876136. Epub 2018 Dec 3.
4
Neutropenic enterocolitis.中性粒细胞减少性小肠结肠炎
World J Gastroenterol. 2017 Jan 7;23(1):42-47. doi: 10.3748/wjg.v23.i1.42.
5
Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy.中性粒细胞减少性肠炎,在广泛使用强化化疗的时代日益受到关注。
Clin Infect Dis. 2013 Mar;56(5):711-7. doi: 10.1093/cid/cis998. Epub 2012 Nov 29.